Overexpression of MTHFD2 is reported in several malignancies and associated with tumor invasion, metastasis and poor prognosis, for instance, the increased expression of MTHFD2 is correlated with tumor growth in renal cell carcinoma, hepatocellular carcinoma, and lung cancer [18–20]. Here, MTHFD2 is linked to lung carcinoma.